SEATTLE & BATON ROUGE, La.--(BUSINESS WIRE)-- #AwardWinningProject--Optimum Energy proudly congratulates Penn State Health on receiving the prestigious 2025 Joseph M. Brillhart IDEA Innovation Award. Presented by the International District Energy Association (IDEA), this prestigious honor recognizes the health system's transformative approach to energy optimization across its Milton S. Hershey Medical Center campus, a nationally recognized facility, and the only combined Level I trauma center for both children and ad.

Dollar Tree Inc (NASDAQ:DLTR) stock is down 9.4% to trade at $87.62 at last glance, brushing off a first-quarter earnings and revenue beat after the discount retailer also issued a lackluster forecast for the current quarter, citing recent tariff uncertainty.

CONCORD, Calif.--(BUSINESS WIRE)--Jopari Solutions, a pioneer in healthcare information technology known for its innovative electronic billing, attachment management, and payment solutions, is pleased to reaffirm its strategic partnership with Waystar, a leading provider of revenue cycle and healthcare payment technology. Together, the two companies are delivering a fully integrated, compliant eBilling solution that streamlines provider workflows and enhances revenue cycle performance across th.

Software stock Asana Inc (NYSE:ASAN) was last seen down 17.3% at $15.71, despite better-than-expected first-quarter results, as revenue growth slowed.

The consensus price target hints at a 38.6% upside potential for FTAI Aviation (FTAI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The mean of analysts' price targets for Agenus (AGEN) points to a 26.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Clean Harbors continues to deliver strong operational results, with resilient Q1 2025 performance and robust pricing power in a challenging environment. Key growth drivers include PFAS regulation tailwinds, Kimball incinerator ramp-up, and long-term demand from North American reshoring and compliance. Valuation remains fair given high margins, strong free cash flow, and disciplined capital allocation for organic growth, M&A, and shareholder returns.

The consensus price target hints at a 54.4% upside potential for Amneal (AMRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The consensus price target hints at a 28.3% upside potential for Rambus (RMBS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The consensus price target hints at a 76.7% upside potential for Zymeworks (ZYME). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The consensus price target hints at a 28.1% upside potential for Energy Transfer LP (ET). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The consensus price target hints at a 106.1% upside potential for Knot Offshore (KNOP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The consensus price target hints at a 398.3% upside potential for Intellia Therapeutics (NTLA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The consensus price target hints at a 47.1% upside potential for HNI (HNI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Sun Life Financial stock gains from growing asset management businesses, its focus on Asia operations, as well as scaling up and integrating U.S. operations.

Trump's tariff hike to 50% on steel imports could ignite gains for NUE, STLD and CLF as demand shifts to U.S. producers.

DAVE, NOMD, GLDD and NGS witness strong cash flow trends and buy signals that point to efficient, growth-ready operations.

BCRX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 4, 2025.

NVDA reclaims the top spot with a $3.45T valuation, and ETFs with heavy exposure to the stock offer investors a way to ride the AI wave.

J.Jill (JILL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.